These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 22840287)

  • 1. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
    J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
    Van Den Eede F; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Claes SJ
    J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.
    Bruehl H; Rueger M; Dziobek I; Sweat V; Tirsi A; Javier E; Arentoft A; Wolf OT; Convit A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2439-45. PubMed ID: 17426095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T; Akiyoshi J; Ichioka S; Tanaka Y; Tsuru J; Goto S; Matsushita H; Hanada H; Isogawa K; Nagayama H
    Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression.
    Yokoyama K; Yamada T; Mitani H; Yamada S; Pu S; Yamanashi T; Matsumura H; Nakagome K; Kaneko K
    Psychiatry Res; 2015 Apr; 226(2-3):494-8. PubMed ID: 25757913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
    Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach.
    Heinzmann JM; Kloiber S; Ebling-Mattos G; Bielohuby M; Schmidt MV; Palme R; Holsboer F; Uhr M; Ising M; Touma C
    Psychoneuroendocrinology; 2014 Nov; 49():229-43. PubMed ID: 25123105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive functioning and cortisol profiles in first episode major depression.
    Hansson PB; Murison R; Lund A; Hammar Å
    Scand J Psychol; 2015 Aug; 56(4):379-83. PubMed ID: 26032571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.